Documo Appoints Veteran Healthcare Executive BJ Boyle to Board of Directors
WILMINGTON, DELAWARE / ACCESS Newswire / June 24, 2025 / Documo , a leading innovator in Cloud Fax and Intelligent Document Processing solutions, announces the appointment of BJ Boyle to its Board of Directors. BJ brings over two decades of expertise in Healthcare Technology and Product Management, currently serving as Chief Product Officer at MacroHealth, where he plays a pivotal role in product strategy and healthcare innovation.
'We are thrilled to welcome BJ Boyle to our board,' said Denis Whelan, CEO of Documo. 'His deep understanding of healthcare technology and product management aligns perfectly with Documo's vision of leveraging modern technology and automation to alleviate administrative burdens in healthcare.'
'Joining Documo's board is an incredible opportunity,' said BJ Boyle. 'I've been thoroughly impressed and excited by the team's unwavering commitment to their mission. Their dedication to innovation and simplifying healthcare communications is truly inspiring, and I'm eager to contribute to their continued success.'
This announcement happens at a pivotal moment in Documo's company history. After a record year of ARR growth in 2024, this addition enables Documo to continue to invest in truly innovative products for the healthcare market.
BJ Boyle's career spans transformative roles at PointClickCare, Matrix Solutions, Oracle Cerner Corporation, and Resource Systems, where he demonstrated a strong commitment to enhancing healthcare delivery through innovative product strategies. He holds a Bachelor of Science in Information Systems from the University of Mount Union, an MBA from Point Park University, and an Executive Certificate in Healthcare Leadership from the University of Missouri-Kansas City.
About Documo
Documo provides secure, cloud-based fax and intelligent document processing solutions with built-in HIPAA compliance. Trusted by thousands of healthcare and regulated industry organizations, Documo simplifies administrative tasks and improves patient outcomes. As a SOC2 and HITRUST-certified organization, Documo maintains the highest security and compliance standards for protected health information, ensuring complete adherence to HIPAA regulations in all document processing operations.
Contact InformationLarisa Summers SVP Marketing 888-966-4922
SOURCE: Documo
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Why famed short-seller Andrew Left says he's betting against Palantir: 'It's become so absurd'
Short-seller Andrew Left says he's betting against Palantir. The AI-powered data company has seen its stock soar this year. Left says he likes the company, but its stock valuation is unjustifiable. Palantir stock seems unstoppable this year, but its astronomical rally has drawn the eye of at least one renowned short-seller. Andrew Left, founder of Citron Research, told Fox Business this week that he's betting against the AI-powered data software company amid its colossal 144% stock surge in 2025. The stock has rallied most recently after reporting strong second-quarter earnings on August 4. Left made it clear that despite Palantir's status as an AI and retail darling, he sees its valuation as extreme. "If this was the greatest company that was ever created and we gave it the same multiples as, let's say Nvidia in 2023, the stock still can get cut by two thirds. And that would be like 35 times sales." Palantir's price-to-sales ratio this month is hovering around 80x, while its forward price-to-earnings ratio was 290x on Thursday. "I've stopped even looking at the ratio because it's become so absurd," Left said. "There's never been a company that has that type of multiple or that type of PE that's not corrected 50%." The short-seller highlighted Palantir's significant following among retail traders, which he suggested is a negative for the stock. Left drew the ire of retail investors when his firm bet against the original meme stock, Gamestop. His other high-profile short bets include Hertz, EV startup Nikola, and Valeant. Once known for his high short-selling activity and social media presence, Left has toned it down recently. In July 2024, the US Securities and Exchange Commission charged him with market manipulation and securities fraud. In May, a federal judge rejected Left's bid to dismiss the case. Left's firm continues to share its reports and perspectives on X. On August 13, it called out an X post by CNBC commentator Jim Cramer when he issued a bullish take on Palantir stock. "Palantir at these levels isn't an "easy money" story; it's a high-multiple, hype-driven narrative," Citron wrote. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 minutes ago
- Yahoo
Malibu Boats, Inc. Announces Earnings Release Date and Conference Call Information for Fourth Quarter and Full-Year Fiscal 2025 Financial Results
LOUDON, Tenn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) announced today that it will release its fourth quarter and full-year fiscal 2025 financial results on Thursday, August 28, 2025, before the market opens. Following the release, the company's management will host a conference call to discuss the results at 8:30 a.m. Eastern Time on the same day. The call will be hosted by Malibu's Chief Executive Officer, Steve Menneto, and Chief Financial Officer, Bruce Beckman. Investors and analysts are invited to listen to the conference call by dialing (844) 695-5523 or (412) 317-0699. Alternatively, interested parties can listen to a live webcast of the conference call by logging on to the Investor Relations section on the Company's website at A replay of the webcast will also be archived on the Company's website for twelve months. About Malibu Boats, Inc. Based in Loudon, Tennessee, Malibu Boats, Inc. (MBUU) is a leading designer, manufacturer and marketer of a diverse range of recreational powerboats, including performance sport, sterndrive and outboard boats. Malibu Boats, Inc. is the market leader in the performance sport boat category through its Malibu and Axis boat brands, the leader in the 20' - 40' segment of the sterndrive boat category through its Cobalt brand, and in a leading position in the saltwater fishing boat market with its Pursuit and Cobia offshore boats and Pathfinder, Maverick, and Hewes flats and bay boat brands. A pre-eminent innovator in the powerboat industry, Malibu Boats, Inc. designs products that appeal to an expanding range of recreational boaters, fisherman and water sports enthusiasts whose passion for boating is a key component of their active lifestyles. For more information, visit or Contacts Malibu Boats,
Yahoo
3 minutes ago
- Yahoo
Activist Starboard buys more Salesforce stock after first demanding change in 2022
By Svea Herbst-Bayliss NEW YORK (Reuters) -Activist Starboard Value, one of the first investors to publicly push Salesforce to make changes three years ago, increased its stake in the U.S. software company by almost 50% in the second quarter, according to a regulatory filing on Thursday. The hedge fund reported owning 1.3 million shares in Salesforce on June 30, compared with 849,679 shares at the end of the first quarter when it boosted its stake by almost 52%. The move comes as the company's stock price has lost nearly 30% since January and is off nearly 9% over the last 12 months. Salesforce, which has a market value of $223 billion, came under intense pressure from a handful of activist investors in late 2022 and early 2023. But many who publicly pushed for changes cut their stakes or exited completely by the middle of 2023 after the company reported better results, added a new director to the board and made other changes. Now the pressure may be increasing again with Starboard, which is known to revisit earlier investments if the company is seen as backsliding on promises, loading up on the stock. While Salesforce's stock price gained nearly 100% in 2023, Starboard's chief executive, Jeffrey Smith, said late last year that the company still had room to become more efficient and profitable. A Starboard spokesperson could not be reached for comment on Thursday. The firm also increased its holding in drugmaker Pfizer by 10.5% to 8.5 million shares, less than a year after unveiling a $1 billion stake in the company and pushing it to improve performance. At Autodesk, where the hedge fund settled its fight with the software design company in April, Starboard cut its stake by nearly 27%, the filing shows. While Thursday's filing is backward-looking, the so-called 13F filings, which detail what U.S. stocks a fund manager owned at the end of the previous quarter, are closely watched for possible investment trends.
